Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality. MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein expression by suppressing translation, inducing mRNA cleavage, and promoting mRNA degradation. miR-122 is the most abundant miRNA...

Full description

Bibliographic Details
Main Author: Kwang-Hoon Chun
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/7/1380
_version_ 1827604564584431616
author Kwang-Hoon Chun
author_facet Kwang-Hoon Chun
author_sort Kwang-Hoon Chun
collection DOAJ
description Hepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality. MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein expression by suppressing translation, inducing mRNA cleavage, and promoting mRNA degradation. miR-122 is the most abundant miRNA in the liver and is responsible for several liver-specific functions, including metabolism, cellular growth and differentiation, and hepatitis virus replication. Recent studies have shown that aberrant regulation of miR-122 is a key factor contributing to the development of HCC. In this review, the signaling pathways and the molecular targets of miR-122 involved in the progression of HCC have been summarized, and the importance of miR-122 in therapy has been discussed.
first_indexed 2024-03-09T06:03:53Z
format Article
id doaj.art-02cd63a2493a40fcb7eaa9ee01c209e5
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T06:03:53Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-02cd63a2493a40fcb7eaa9ee01c209e52023-12-03T12:06:07ZengMDPI AGPharmaceutics1999-49232022-06-01147138010.3390/pharmaceutics14071380Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular CarcinomaKwang-Hoon Chun0Gachon Institute of Pharmaceutical Sciences, College of Pharmacy, Gachon University, Incheon 21936, KoreaHepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality. MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein expression by suppressing translation, inducing mRNA cleavage, and promoting mRNA degradation. miR-122 is the most abundant miRNA in the liver and is responsible for several liver-specific functions, including metabolism, cellular growth and differentiation, and hepatitis virus replication. Recent studies have shown that aberrant regulation of miR-122 is a key factor contributing to the development of HCC. In this review, the signaling pathways and the molecular targets of miR-122 involved in the progression of HCC have been summarized, and the importance of miR-122 in therapy has been discussed.https://www.mdpi.com/1999-4923/14/7/1380miR-122hepatocellular carcinomamolecular targetssignaling pathwaysmetastasis
spellingShingle Kwang-Hoon Chun
Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
Pharmaceutics
miR-122
hepatocellular carcinoma
molecular targets
signaling pathways
metastasis
title Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_full Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_fullStr Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_full_unstemmed Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_short Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
title_sort molecular targets and signaling pathways of microrna 122 in hepatocellular carcinoma
topic miR-122
hepatocellular carcinoma
molecular targets
signaling pathways
metastasis
url https://www.mdpi.com/1999-4923/14/7/1380
work_keys_str_mv AT kwanghoonchun moleculartargetsandsignalingpathwaysofmicrorna122inhepatocellularcarcinoma